Small Bowel
The Latest
Diet-microbiome links drive IBD inflammation
-
by Doug Brunk
Advanced genetic testing of gut bacteria shows certain microbes and their byproducts may help lower inflammation in Crohn’s disease and ulcerative colitis.
Advances in Crohn’s disease therapies show similar safety
-
by Doug Brunk
Large claims analysis finds no significant differences in serious infections, VTE, or MACE across biologics and JAK inhibitors.
Genetic risk tied to IBD severity
-
by Doug Brunk
Large Danish cohort links higher polygenic risk scores to worse outcomes, including surgery and intensive treatment, with distinct patterns in Crohn’s disease and ulcerative colitis.
Creeping fat in Crohn's may turn harmful
-
by Doug Brunk
Even though it is common, the condition has not been studied much.
Postoperative Crohn’s: What’s changed?
-
by Doug Brunk
The concept of reusing anti-TNF therapy after surgery is gaining traction.
With a little help from my friends: What gastrointestinal pathologists need to know from gastroenterologists
-
by Raul S. Gonzalez, MD
Why better communication between gastroenterologists and pathologists matters for patient care.
Green endoscopy: Practical strategies to reduce environmental impact in GI practice
-
by Rabia de Latour, MD
There are plenty of opportunities for gastroenterologists, ambulatory surgery centers, endoscopy units, and outpatient clinics to implement changes that reduce GHG emissions.
Hospital care for IBD gets practical refresh
-
by Doug Brunk
“IBD experts around the country are receiving many more calls from community gastroenterologists for advice treating their hospitalized patients,” Dr. Shirley Cohen-Mekelburg said.
New Crohn's data spotlight promising therapies
-
by Doug Brunk
Beyond drugs, interest is growing in diet-based treatments.
Tiny plastics may harm gut and liver health, review finds
-
by Doug Brunk
“Our aim was to start conversations between clinicians and their patients about this emerging risk,” Dr. Priyata Dutta explained.
Wearable devices show growing potential in IBD care
-
by Doug Brunk
"The use of wearables envisions a future where the assessment of disease activity would be ongoing, continuous, and free of clinical visits."
Four reasons to add intestinal ultrasound to your practice
-
by Doug Brunk
“It's really made its way already into the mainstream of IBD care,” Dr. Rishika Chugh said.
Upadacitinib in pediatric IBD: 52-week results
-
by Doug Brunk
Response in those with ulcerative colitis was especially strong.
FMT improves IBD remission, meta-analysis suggests
-
by Doug Brunk
Researchers evaluated 7 trials involving 542 patients with UC or CD.
Celiac markers unaffected by diet, proteomic analysis reveals
-
by Doug Brunk
“I was excited to find not just one but four markers that were invariant to diet."
JAK inhibitors show superior real-world efficacy in microscopic colitis
-
by Doug Brunk
“These findings pave the way for dedicated prospective trials and highlight evolving therapeutic strategies."
Practice update: Refractory constipation
-
by Doug Brunk
Longstanding concerns about chronic stimulant laxative use are described as unfounded.
When gut-brain disorders affect eating in adults
-
by Doug Brunk
"Restrictive eating in DGBI is common beyond specialist clinics and highlights the need for integrated multidisciplinary care."
AGA strengthens payor ties to ease admin burden
-
by Doug Brunk
“We view this as an opportunity to work together to alleviate some of these burdens, and I will say that hearing the perspective from payors has been very eye-opening.”
Building effective community-based IBD care: Key challenges and opportunities
-
by Doug Brunk
“I fear practices will lose their relevance if they do not start building systems and processes for cognitive care pathways like IBD."
In memoriam: Dr. Kim L. Isaacs
-
by John Allen, MD, MBA, AGAF
Dr. Isaacs was a treasured physician, teacher, mentor, and researcher at the University of North Carolina.
AGA unveils new clinical practice guideline for Crohn's disease
-
by Doug Brunk
The guidelines are living documents that “will be updated quarterly, allowing for rapid evolution as new data become available.”
Approach to weight management in GI practice
-
by Colleen R. Kelly, MD
As gastroenterologists, we treat a number of conditions that are caused or worsened by obesity.
Microbiome: COVID-19's hidden factor?
-
by Kerri Miller
Pre-pandemic microbiome composition influences severe disease outcomes years later in a population study.
Bariatric surgery vs GLP-1s: GERD risk
-
by Kerri Miller
Propensity-matched analysis of over 80,000 patients reveals bariatric surgery nearly doubles five-year esophageal complication rates compared with GLP-1 RA therapy.
GLP-1s and tirzepatide: Similar GI risk
-
by Kerri Miller
Real-world data show similar rates of severe GI events with semaglutide, dulaglutide, and tirzepatide, reinforcing comparable safety across agents in routine care.
Mediterranean vs traditional diet for IBS
-
by Kathryn Wighton
The Mediterranean diet demonstrated greater symptom relief and patient adherence than traditional dietary advice.
Nutritional IBD screening tools ranked
-
by Kerri Miller
"MIRT might be the NSTs of choice to predict defined malnutrition and low-Fat Free Mass Index at 6 months follow-up in a cohort of inactive/mildly active IBD patients."
Global IBD trial experts agree on steroid standards
-
by Teraya Smith
New guidance issued on how steroids should be managed in clinical trial settings.
Intestinal ultrasound offers prognostic value in IBD pregnancy
-
by Kerri Miller
"We rely very little on symptoms in pregnancy — they’re so unreliable — and instead target fecal calprotectin under 100 and sonographic remission."
Improving care for patients from historically minoritized and marginalized communities with disorders of gut-brain interaction
-
by Rosa Yu, MD, Jennifer Dimino, MD, Christopher Velez, MD, GI and Hepatology News
Improving care for sexual and gender minority patients with disorders of gut-brain interaction
-
by Kara J. Jencks, MD, Christopher Velez, MD
Improving care for sexual and gender minority patients with disorders of gut-brain interaction
-
by Kara J. Jencks, MD, Christopher Velez, MD
Clinical research in early career academic medicine
-
by Lauren D. Feld, MD, Kathy Nguyen, Katherine Cooper, MD, Loren Galler Rabinowitz, MD, Amiko M. Uchida, MD
Avoid getting stuck: A practical guide to managing chronic constipation
-
by Hamza Salim, DO, Anni Chowdhury, DO, Lavanya Viswanathan, MD, MS
Avoid getting stuck: A practical guide to managing chronic constipation
-
by Hamza Salim, DO, Anni Chowdhury, DO, Lavanya Viswanathan, MD, MS
The complexity of this condition should be appreciated and understood in order for a complete and thorough evaluation.
A paradigm shift in evaluating and investigating the etiology of bloating
-
by Rajan Singh, PhD, Baharak Moshiree, MD, AGAF
The AGA Future Leaders Program: a mentee-mentor triad perspective
-
by Parakkal Deepak, MBBS, MS, Edward L. Barnes, MD, MPH, Aasma Shaukat, MD, MPH
A simplified approach to pelvic floor dysfunction
-
by Ayesha Khan, DO, Raakhi Menon, DO, Lindsay Allen, PT, DPT, MBA, Brooke Corning, MD
Achieving promotion for junior faculty in academic medicine: An interview with experts
-
by Vineet S. Rolston, MD, Sophie Balzora, MD, Mark A. Schattner, MD
What gastroenterologists need to know about the 2024 Medicare payment rules
-
by GI and Hepatology News
From private practice to academic medicine: My journey and lessons learned
-
by Katie Hutchins, MD
Immune checkpoint inhibitor–related gastrointestinal adverse events
-
by Joshua Kwon, MD, Paul T. Kröner, MD, MSc
Integrating intestinal ultrasound into inflammatory bowel disease training and practice in the United States
-
by Noa Krugliak Cleveland, MD, David T. Rubin, MD